Yatin Suneja Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
52
Avg Return
Past Year
Past Year
40%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
93.8%
Neutral
6.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $350 |
84%
upside
| 1 | +17% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Buy
Maintained
| $150 |
62%
upside
| 2 | +404% |
0
%
| 10 Oct ‘25 9 days ago |
|
|
|
Buy
Maintained
| $8 |
708%
upside
| 2 | +9.1% |
0
%
| 8 Oct ‘25 11 days ago |
|
|
|
Buy
Maintained
| $20 |
119%
upside
| 1 | +46% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Buy
Reiterated
| $1,070 |
27%
upside
| 2 | +6.6% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $21 |
22%
upside
| 1 | +13% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 2 | +52% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $100 |
181%
upside
| 1 | +24% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $75 |
521%
upside
| 1 | +4.4% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $15 |
426%
upside
| 1 | +27% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $815 |
41%
upside
| 1 | -1.6% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $175 |
25%
upside
| 1 | +5.2% |
0
%
| 1 Aug ‘25 2 months ago |
|